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Strengths and limitations of this study
 ► This study is the first to explore the views and expe-
riences of UK clinicians who provided postnatal care 
of women who experienced hypertensive disorders 
in pregnancy, a neglected aspect of maternity care.
 ► This study reflects increasing evidence that more 
women are commencing pregnancy at increased 
risk of developing hypertensive disorders in preg-
nancy due to older maternal age, higher body mass 
indexes and other medical complications.
 ► This study included midwives, obstetricians, gen-
eral practitioners, obstetric physicians and a health 
visitor, reflecting a range of clinical practice across 
secondary and primary care settings.
 ► The study setting included inner city and urban ar-
eas in the south of England. It is possible that cli-
nician experiences in other parts of the UK could 
reflect differences in populations of pregnant and 
postnatal women.
AbStrACt
Objectives To explore clinicians’ views and 
experiences of caring for postnatal women who had 
hypertensive disorders of pregnancy (HDP), awareness 
of relevant National Institute for Health and Care 
Excellence (NICE) guidance to inform their postnatal 
management, the extent to which NICE guidance was 
implemented, barriers and facilitators to implementation 
and how care could be enhanced to support women’s 
future health.
Design A qualitative study using semistructured 
interviews. Thematic analysis was used for coding and 
theme generation.
Setting Four National Health Service maternity units and 
three general practice clinics in South- East and South- 
West London.
Participants A maximum variation, purposive sample of 
20 clinicians with experience of providing postnatal care to 
women following HDP.
results Four main themes were generated: variation 
in knowledge and clinical practice; communication 
and education; provision of care; locus of responsibility 
for care. Perceived barriers to implementation of NICE 
guidance included lack of postnatal care plans and 
pathways, poor continuity of care, poor antihypertensive 
medication management, uncertainty around responsibility 
for postnatal care and women’s lack of awareness of the 
importance of postnatal follow- up for their future health. 
Some clinicians considered that women were discharged 
from inpatient care too soon, as primary care clinicians 
did not have specialist knowledge of HDP management. 
Most clinicians acknowledged the need for better planning, 
communication and coordination of care across health 
settings.
Conclusions Evidence of longer term consequences 
for women’s health following HDP is accumulating, with 
potential for NICE guidance to support better outcomes 
for women if implemented. Clinicians responsible for 
postnatal care following HDP should ensure that they are 
familiar with relevant NICE guidance, able to implement 
recommendations and involve women in decisions about 
ongoing care and why this is important. The continued 
low priority and resources allocated to postnatal 
services will continue to promote missed opportunities 
to improve outcomes for women, their infants and 
families.
IntrODuCtIOn
Hypertensive disorders of pregnancy (HDP) 
include gestational hypertension, chronic 
hypertension, pre- eclampsia–eclampsia and 
pre- eclampsia imposed on chronic hyper-
tension. HDP are among the most severe 
health problems experienced by women 
during, and in some cases, following preg-
nancy, and a leading cause of direct maternal 
deaths globally.1 Although there is no inter-
national consensus on diagnostic criteria,2 
HDP affect around 5%–10% of women, with 
rates increasing due to associations with older 
maternal age, obesity and diabetes.3 4
Much of the literature to date has focused 
on pregnancy management of HDP,2 5 but 
focus is increasing on postnatal manage-
ment,2 6 7 reflecting increasing evidence of 
risk of recurrence of HDP in subsequent preg-
nancies. An individual participant data (IPD) 
meta- analysis reported a recurrence rate of 
HDP of 20.7% based on 22 cohort studies 
included in the IPD; recurrence manifested as 
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pre- eclampsia in 13.8% of the studies, gestational hyper-
tension in 8.6%, and haemolysis, elevated liver enzymes 
and low platelet count syndrome in 0.2%.8
Adverse outcomes are not only restricted to the index 
pregnancy or subsequent pregnancies, with large observa-
tional studies and systematic reviews reporting that HDP 
increase a woman’s lifetime risk of cardiovascular disease 
(CVD) two- to five- fold compared with women who were 
normotensive.9–11 An earlier systematic review and meta- 
analysis also found women who had pre- eclampsia had 
significantly increased odds of a fatal or diagnosed cere-
bral vascular accident and hypertension in later life.12
Although underlying mechanisms are currently not well 
understood, given high and persistent levels of maternal 
morbidity, appropriate and timely clinician input to 
assess postnatal risk and promote health and well- being 
following HDP is imperative. Increased awareness of 
which women may be at risk, together with advice offered 
to women on self- management of potentially modifiable 
risk factors such as weight management and tobacco 
smoking cessation,3 13 highlighted the potential opportu-
nity for postnatal care to benefit shorter and longer term 
health.
In the UK, the majority of women access maternity 
care provided by the National Health Service (NHS). All 
women, including those who had HDP, will be discharged 
following birth to routine contacts with a range of clini-
cians including midwives (for the first 10–14 days post-
natally) and health visitors, and advised to make an 
appointment at 6–8 weeks with their general practitioner 
(GP; family doctor) at which point they are discharged 
from maternity care. Some women may be offered a 
follow- up consultation with their obstetrician and/
or another member of the medical team, but this will 
depend on local clinical arrangements and capacity.14
The National Institute for Health and Care Excellence 
(NICE) aims to improve outcomes for patients in the 
UK who receive NHS care through publication of guid-
ance and technology appraisals on provision of effective 
health, public health and social care across a range of 
areas, including maternity care. This includes guidance 
on the routine postnatal care all women and their infants 
should be offered,14 and guidance for women who had 
HDP,3 13 which includes postnatal lifestyle behaviours, 
breastfeeding considerations and consideration of longer 
terms risks to a woman’s health.
Despite increasing numbers of women diagnosed with 
HDP, little is known about clinicians’ management of 
their postnatal care. The aim of this study was to explore 
the extent to which planning and provision of care for 
women who had HDP reflected the then available NICE 
guidance on HDP13 and routine postnatal care.14
MethODS
Study objectives were to explore:
 ► Clinicians’ views and experiences of caring for women 
who had HDP, including awareness of relevant NICE 
guidance and the extent to which planning, and 
provision of care reflected guidance.
 ► Barriers and facilitators to implementation of NICE 
recommendations relevant to postnatal management 
following HDP.
 ► Views of where service revisions could be introduced 
to better meet women’s needs and improve quality 
of care, including the role of multidisciplinary team 
(MDT).
Setting
Recruitment took place across four London NHS 
maternity units and three local general practices based 
in South- East and South- West London. All four units 
provided specialist maternity care for women with more 
complex pregnancies and/or whose infants required 
neonatal intensive care, in addition to women classed 
as having a low- risk pregnancy. Three of the maternity 
units were tertiary centres, with specialist services to treat 
women and/or infants with the most severe complica-
tions of pregnancy and birth and were referral centres for 
units without these services. The fourth unit was a district 
general hospital. The general practices were all based in 
the same locale as three of the maternity units and offered 
a range of medical services for the local general popula-
tion, including women living in the hospital catchment 
area. All of the study sites provided care to ethnically and 
culturally diverse populations.
recruitment and participants
A maximum variation sampling strategy15 16 was used to 
recruit a range of clinicians responsible for providing 
postnatal care for women who had HDP. This strategy 
was employed to provide a comprehensive understanding 
of views and experiences of care offered in- line with 
the study aim and objectives. Clinicians were identified 
by local study collaborators as having responsibility for 
providing postnatal care, in- line with study inclusion 
criteria. Identified clinicians were contacted by a member 
of the research team (AB) who explained the purpose of 
the study and what participation would involve. Those 
who agreed to participate provided written informed 
consent prior to the research interview.
Data collection
The interview schedule was developed by the authors with 
input from a stakeholder group of local clinicians with 
expertise in HDP and a patient and public involvement 
group comprising women who had previously experi-
enced HDP. Interviews were conducted face to face by 
AB, or if not possible, by telephone, and were intended 
to be semistructured, but conversational in nature. This 
approach allowed for standard questions to be asked 
in all interviews, but permitted topics of interest to be 
probed further, additional questions to be asked by the 
interviewer if appropriate, and informed exploration of 
topics in subsequent interviews. Interviews, which lasted 
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Table 1 Study ID number and clinical background of 
participants
ID Role ID Role
1 General practitioner 11 General practitioner
2 General practitioner 12 Consultant obstetrician
3 General practitioner 13 Specialist midwife for 
hypertension
4 Consultant obstetrician 14 Consultant midwife
5 Obstetric physician 15 Consultant obstetrician
6 Community midwife 16 Research midwife and 
midwifery matron
7 Specialist midwife for 
hypertension
17 Consultant obstetrician
8 Clinical research fellow 
(obstetric trainee)
18 Community midwife
9 Consultant midwife 19 General practitioner
10 Consultant obstetrician 20 Health visitor
for around 30 min, were transcribed verbatim and tran-
scripts were anonymised and checked for inaccuracies.
Analysis
Data were managed in NVivo V.12 and analysed using 
thematic analysis,17 18 a process characterised by induc-
tive, consultative and open coding of the data.19 The six- 
phase process of thematic analysis17 was followed, which 
entails familiarisation, generating initial codes, searching 
for and then reviewing themes, defining and offering 
names for those themes. All data were coded by AB with 
20% of the transcripts independently coded by Y- SC. The 
coding was reviewed by SAS. The researchers met regu-
larly to discuss and revise the themes and ensure analytical 
rigour, with any discrepancies discussed to ensure coding 
and analysis satisfied all perspectives.20 Themes, centred 
on a core organising concept to sustain its explanatory 
power within the data, were developed from the codes17 
following discussions. All researchers agreed on the final 
themes.
Sample size sufficiency, data adequacy and theme satu-
ration were assessed during the analysis process using 
existing models of thematic concordance and data 
quality.21–23 This meant data were fully saturated with the 
number of participants recruited, and common themes 
could be found across the dataset, with no new themes 
being generated by the time the last transcript was 
analysed.
PAtIent AnD PublIC InvOlveMent
Women who had experienced HDP informed the original 
research questions and study design. These women were 
not involved in the recruitment, or conduct of this study. 
We presented the findings and discussed the implications 
of these through a meeting advertised nationally via the 
charity action on pre- eclampsia, to women who experi-
enced HDP.
reSultS
Thirty- four clinicians were invited to interview, 20 of 
whom agreed to participate, representing the clinical 
backgrounds of interest (see table 1). Five GPs; six obste-
tricians; seven midwives (including case load, consul-
tant and specialist hypertension midwives); one clinical 
research fellow (obstetric trainee) and one health visitor 
(a nurse or midwife who has undergone additional 
training in community public health nursing) were 
recruited and interviewed.
The analysis generated four main themes: variation 
in knowledge and clinical practice; communication 
and education; provision of care; locus of responsibility 
for care, each with two to four subthemes, which are 
presented in the following sections.
variation in knowledge and clinical practice
Clinicians’ lack of assessment and knowledge
Clinicians were aware of the importance of identifying 
postnatal women with HDP, but some acknowledged a 
general lack of assessment of women’s blood pressure 
(BP) during the postnatal period due to the relatively low 
incidence of adverse outcomes, and lack of recognition of 
HDP among non- specialist clinicians.
I think there are other concerns about undertreated 
hypertension, which we measure poorly. We probably 
under measure it and therefore under report it be-
cause we will get away with it most of the time, because 
strokes and eclamptic fits are rare in this population 
but I think… I think walking around with really high 
blood pressure is probably not good short- term or 
long- term. (Participant 4—Consultant Obstetrician)
Concerns were also raised about non- specialists’ aware-
ness of side- effects of antihypertensive medication they 
prescribed, as one of the specialist midwives described:
The GPs, I’m not sure how much they know… just 
last week (a woman) had been started on medica-
tion called methyldopa [antihypertensive drug] by 
the GP, which is not recommended postnatally be-
cause it makes you very depressed, so that’s why she 
thinks she wasn’t feeling herself at all. We immediate-
ly stopped that medication. She said that that GP is 
not her normal GP, it was a locum GP, so maybe they 
just didn’t know, so it happens sometimes, and they 
may not know. (Participant 7—Specialist Midwife for 
Hypertension)
The consensus of those interviewed was that more 
had to be done to educate clinicians, particularly those 
working in primary care settings. Several interviewees 
suggested postnatal care should be provided by specialists 
in hypertensive care, as primary care clinicians may not 
have capacity or relevant specialist knowledge.
…we definitely need to re- evaluate the whole post-
natal pathway because it’s definitely, definitely inad-
equate……… I think what women actually need is 
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direct access to a midwife or an obstetrician that they 
can speak to at any time and get seen at any time… 
And I mean, obviously, that can’t just be any midwife 
or any doctor, I think it needs to be someone with a 
specialist interest in hypertension. (Participant 13—
Specialist Midwife for Hypertension)
Clinical decision-making based on BP range
Clinicians offered varied responses when asked what BP 
parameters they used to manage antihypertensive medi-
cation. Some acknowledged that practice varied between 
clinicians, with a lack of adherence to relevant NICE guid-
ance described.
…within our hypertension in pregnancy guideline 
we have got a section on postnatal, with a guide on 
which antihypertensives to prescribe, what schedule 
of reviews should be and fit with what the NICE ad-
vice is [on BP management]. How effectively that’s 
delivered, I think, is quite variable. So, you can have 
it on paper, but it doesn’t necessarily translate well 
to what people do. (Participant 15—Consultant 
Obstetrician)
Individual experiences of management of women 
with HDP shaped the practice of some clinicians. Those 
with more experience of managing HDP expressed 
greater confidence in their decisions about postnatal 
management:
NICE say [follow- up checks at] two weeks and 
six weeks, but as a practicing clinician and on the 
shop floor and having opportunity, I’m far more, I 
would say, aggressive in making sure that we’re seeing 
them more often. I think that those kind of timelines, 
five days, two weeks and six weeks, you’ve got missed 
opportunities and actually, women need more or less, 
and less is as important as more. I’ve seen a lady today 
that I’ve had to reduce the antihypertensive because 
nobody is brave enough to do that, even though 
they’ve seen two other clinicians. (Participant 5—
Obstetric Physician)
The need to regularly review women was viewed 
as important to ensure antihypertensive medication 
management was appropriate.
…blood pressure’s taken on one day may not be rep-
resentative of which way they’re heading. There may 
be other factors in the immediate post- birth period. 
Other variables quite strongly affect blood pressure 
and therefore your choice of antihypertensive may be 
appropriate at this moment but may need escalation 
up or down titration, depending on how factors play 
out. (Participant 4—Consultant Obstetrician)
Communication and education
Communication and support between services
Clinicians described several barriers to effective commu-
nication following inpatient discharge, including lack of, 
or no direct contact with, clinicians involved in a woman’s 
pregnancy care and lack of continuity of postnatal care 
provider:
I think communication can be quite tricky at times. 
I know particularly in our area, communication with 
the midwives isn’t quite as easy as it could be in trying 
to track down who is the actual person that’s been 
seeing this lady—quite often, it tends to be different 
midwives. (Participant 20—Health Visitor)
Clinicians were conscious of ‘gaps’ between care 
provided by specialists in HDP management in hospital 
and routine primary care services. They also acknowl-
edged the importance of effective communication 
between clinicians within and across healthcare settings 
for planning the timing and transition of a woman’s 
care from secondary to primary care. Some clinicians 
considered that women were discharged too soon from 
specialist services to primary care teams and could benefit 
from longer contact with the secondary care team:
Ultimately, these women need lifelong care and they 
need to go back to their GP so it’s about at what time 
point we transition them. I think it’s too early, at the 
moment. … I think the transition should be in a 
much more organised and robust way so that women 
know that they have a schedule of reviews delivered by 
the maternity services and then they have a six week 
check, which actually works quite well and is bedded 
in. (Participant 15—Consultant Obstetrician)
Women’s engagement with advice and education
Effective provision of information for women was viewed 
as key to assist their understanding the severity of their 
disease, and encourage adherence to postnatal manage-
ment plans, taking prescribed medication as advised in 
terms of dosage and consistent timing, and engaging with 
primary care for ongoing postnatal monitoring. It was 
noted that women needed to engage with the informa-
tion offered, with some women more able to engage than 
others for a variety of reasons.
Sometimes it’s really easy to give advice and some-
times it’s really difficult and I wouldn’t say it’s in re-
lation to someone’s high blood pressure or diabetes 
or anything like that, it’s just down to the woman. 
Some women are going to listen and some just aren’t. 
(Participant 6—Community Midwife)
Several interviewees referred to the timing of when 
information was offered could influence how well women 
engaged with understanding the impacts of HDP, recom-
mending that information should be provided to women 
at the earliest opportunity and reiterated at every care 
contact:
It may have all been partly intra- partum. Some of 
them it’ll be only, “Oh, your blood pressure went up 
actually in labour, and then we want to get the baby 
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delivered”. So sometimes it’s quite a short period, 
and it’s a period where lots of other things are going 
on, and they may not have absorbed all those messag-
es. (Participant 19—General Practitioner)
Point of discharge from inpatient care (women with 
HDP are generally recommended to birth under the 
care of the obstetric team)13 was viewed as a particu-
larly pertinent time to commence a discussion about a 
woman’s postnatal care choices, including options for 
contraception:
I think all women who are hypertensive at delivery 
should be given a leaflet where all this primary infor-
mation is given to them so that they understand that 
they look long term for contraceptive options. There 
should be a package that everyone with hypertension 
in pregnancy should receive at the point of discharge 
with more information links if she wants more later 
on… (Participant 12—Consultant Obstetrician)
Others also suggested women needed better antenatal 
education to enable them to more appropriately psycho-
logically prepare for any potential pregnancy complica-
tions, such as HDP.
…I hope that this would prepare them better, that if 
something happens—if their pregnancy takes a slight 
deviation from their expectations—then they’re bet-
ter prepared to deal with that, psychologically. I think 
that would have an impact on how they behave post-
natally… (Participant 8—Clinical Research Fellow)
There was also recognition among clinicians that the 
postnatal period was a time when women often prioritised 
their newborn infants’ health over their own, certainly in 
the first few months as they adjusted to new family life but 
also a time when women wanted to feel ‘normal’ again:
Compliance post- delivery is understandably very 
poor because they’re busy with their babies so who’s 
got time to take tablets three times a day? And they 
don’t feel well on these tablets so don’t particular-
ly want to take them. (Participant 10—Consultant 
Obstetrician)
…women don’t always take the drugs that are 
prescribed to them… so it may be that they honestly 
forget, maybe that life is just very busy, but sometimes 
it’s they just don’t want to take the medication. In 
pregnancy, that might be because they’re worried 
about the effects on the baby. Once they’ve had the 
baby, it’s because they want to be normal. They’re 
sick of being ‘ill’. They’ve had the baby; they want to 
be like everyone else who’s had a baby. (Participant 
9—Consultant Midwife)
Provision of care
Improving care
Some participants considered postnatal referral pathways 
should be standardised to reduce risk of adverse outcomes 
if women did not receive prompt care when needed:
There should be a standardised postnatal pat-
tern where this is where the woman goes… how 
is it okay for a woman to be sitting in a big waiting 
room with a blood pressure of, you know, more than 
160/110, it’s ridiculous, you know, you’re increas-
ing her risk of having a stroke and what not, or ec-
lamptic fit. (Participant 13—Specialist Midwife for 
Hypertension)
Other suggestions for improving care included review 
of risk factors by an appropriate MDT, who could develop 
a plan for longer term follow- up, to be shared with the 
woman’s GP, alongside information for women on longer 
term health risks:
If everything is stable, they [women] should be seen 
again at six weeks where you can discuss future risks. 
You need to see whether there is a residual disease, 
whether you need to do more investigations and re-
fer to aligned specialities and arrange for long- term 
follow- up by the GP and inform them about the 
long- term cardiovascular risks and contraception. 
(Participant 12—Consultant Obstetrician)
Barriers to care reflected need for regular monitoring 
of women’s BP, medication review and ensuring infor-
mation on drug safety was adequate, especially if women 
were breast feeding:
Before they leave hospital, there are barriers in terms 
of regular, accurate measurement of blood pressure, 
provision of effective medication, choice of antihy-
pertensive with regards to breastfeeding, adequacy of 
information, adequacy of safety data on antihyperten-
sives and breastfeeding. (Participant 4—Consultant 
Obstetrician)
Limited capacity effects care provision
Clinicians stressed that a lack of capacity across the mater-
nity services was an important barrier to appropriate and 
timely care especially in the immediate postnatal period.
I think the staff feel under- resourced, overstretched, 
not well supported and with a long list of jobs that 
they’re not able to prioritise what’s important and 
what’s not so important and then meet the expecta-
tions of the mothers……… sometimes the midwife, 
if they find that woman is hypertensive, they’re not 
able to get the medical staff to come and address that 
issue because the doctor’s based on labour ward or 
elsewhere. (Participant 8—Clinical Research Fellow)
It was also highlighted that GPs had limited capacity 
due to their workloads and waiting times for women to 
get an appointment to see them, to engage effectively 
with postnatal women, meaning that follow- up contacts 
were not tailored to need.
I think a lot of the work can be done by general prac-
tice, but I think, general practice is struggling and 
also, it’s engagement with the woman. It’s both ways. 
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I think all practices have the ability to do this, but 
the woman has to engage with them as well. If they’re 
being told they’ve got to wait a long time for a GP 
appointment, they won’t engage. (Participant 5—
Obstetric Physician)
For some clinicians, despite limited capacity, they went 
‘above- and- beyond’ their role especially if a woman’s 
health deteriorated:
I tell them that they can contact me directly… it’s just 
a responsibility I’ve taken on myself as I don’t want 
them to feel alone postnatally and I don’t want them 
to have to go through A&E. Sometimes I’m not here 
and they do have to go through A&E but if they call… 
I will see them, and they won’t have to sit in A&E. I’ll 
just do it ad hoc, grab a consultant and just say, “Look 
at this patient now!” which isn’t right, it’s not fair. I 
shouldn’t have to do that. (Participant 13—Specialist 
Midwife for Hypertension)
Need for medical care
Participants discussed how raised BP, plus adverse blood 
results could result in a longer inpatient stay following 
the birth, but women were often unaware their BP could 
remain unstable postnatally:
…anybody whose blood pressure is 140/190, on two 
occasions, more than four hours apart, or 150/100 
with another factor, such as raised PCR, raised creat-
inine level, raised ART, low platelets……… I say that, 
postnatally, we do need to monitor you……… some-
times, the women are under the impression that once 
they have given birth, their blood pressure will sta-
bilise. I, personally, always say, it’s kind of three days 
before we can see what your blood pressure is do-
ing. So, usually, a hospital admission is round about 
three days, postpartum. (Participant 16—Research 
Midwife & Midwifery Matron)
Participants in some cases described how they tried to 
ensure women who required a longer inpatient stay had 
a room of their own in an effort to deter women from 
discharging themselves from hospital:
So quite often, if they’ve got a prolonged stay, you 
try and find them a side room, so that at least they 
have a bit of privacy but it’s really difficult to get them 
a side room because, obviously, there are prioritised 
women who have had a bereavement or a traumatic 
labour or something. That’s often the difficulty I en-
counter is trying to get them to stay on the postnatal 
ward and discharge them safely. A lot of them want to 
self- discharge beforehand. (Participant 8—Clinical 
Research Fellow)
Subsequent pregnancies
The risks to maternal health in subsequent pregnancies 
were also referred to by the participants.
If it’s somebody who’s already got a pre- existing prob-
lem with hypertension and they were thinking about 
subsequent pregnancies, then we’d want to make 
sure that they were on an antihypertensive that was 
safe in pregnancy in case they were to fall pregnant 
again. (Participant 1—General Practitioner)
Likewise, interviewees discussed the importance of 
maintenance of a woman’s longer term health after HDP, 
including counselling women on reducing their risk of 
HDP in a future pregnancy:
So, we talk about exercise, diet, maintaining normal 
BMI and having your blood pressure checked, may-
be every three, six months, with the GP, just to make 
sure that they are fit following their pregnancy. I will 
emphasise that they less likely to have a recurrence 
of their pre- eclampsia during future pregnancies if 
their BMI is normal and they don’t have any health 
issues. So, we talk about long term health, off the 
back of the counselling. (Participant 17—Consultant 
Obstetrician)
locus of responsibility for care
Responsibility placed on the clinician
Clinicians based in secondary care settings clearly 
acknowledged their responsibilities when managing 
women with HDP, but felt they could better fulfil these 
if continuity of care tailored to women’s individual BP 
results were implemented.
They are seen on the postnatal ward. I would love to 
have more continuity, but we don’t. By and large I 
aim to make a postnatal plan of care… but the in-
dividualisation of that, it needs to take into account 
what their blood pressure is postnatally and how rap-
idly it falls. (Participant 4—Consultant Obstetrician)
This contrasted with those in primary care settings who 
considered NICE guidance lacked clarity with respect to 
their clinical responsibilities.
I do think that there is a little bit of a difficulty with 
knowing what the expectation is of a GP when you’ve 
got women who are quite complicated. I think that’s 
something that has definitely come up in our prac-
tice, where you’re not really sure what the responsi-
bility is or what the frequency with which you should 
be checking it is, and I don’t think that the NICE 
guidance is so clear on that. (Participant 11—General 
Practitioner)
The overall feeling from secondary care clinicians was 
that postnatal women in some circumstances (in this case, 
women who developed gestational hypertension) were 
perhaps best managed by them; however, the maternity 
services did not have capacity or funding for this.
I absolutely think there needs to be a robust hando-
ver and a longer- term transition. But, I think, women 
who developed gestational hypertension are still at 
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risk of post- partum pre- eclampsia and often very la-
bile for the first couple of weeks and need quite a lot 
of adjusting and weaning. I think if you’re delivering 
women centred care, this should happen alongside 
assessing her well- being, her baby and I don’t think, 
necessarily, the GP is best placed to do that. I think 
that would be a much more robust system, rather than 
this, “Oh you've had your baby”; and immediately you 
transition back and go and see your GP. (Participant 
15—Consultant Obstetrician)
Furthermore, clinicians discussed that tailoring post-
natal care to an individual woman could support appro-
priate clinical decision- making, as getting to know the 
woman would enable the clinician (in this case a midwife) 
to note changes in her postnatal health and well- being:
Tailor that care and know the women… from that, 
you’re in a key position as a midwife to make real 
clinical decisions because you know them, you know 
something’s not right……… You can talk to them 
about things and you just see a change in them, you 
pick up stuff about them that might have been lost by 
a different midwife if every time if they’re just doing a 
urine [test] and blood pressure and then off you go. 
(Participant 14—Consultant Midwife)
Responsibility placed on the woman
Some of the clinicians felt the woman also had to take 
responsibility for her health following HDP, particularly 
with respect to monitoring of their BP.
Yes, I suppose they would be seen in the clinic if the 
woman came here for an appointment to discuss [her 
hypertension]. Otherwise, I haven’t personally been 
involved with any cases. (Participant 3—General 
Practitioner)
They’ve got to think about contraception, and long 
term if they have got a high BMI, exercising, eating 
sensibly, all these sorts of things. Then they’ll have a 
follow- up with their blood pressure more frequently. 
I usually say to them if they’ve had it, that they should 
have their blood pressure checked more frequently. 
(Participant 18—Community Midwife)
There was also the recognition that it was the woman, 
not the GP, who would arrange postnatal follow- up. One 
of the GPs felt women would only be seen if they (the 
woman) took the initiative and made an appointment to 
see their GP.
Usually, the women themselves have known and 
they’ve been told to come and see their GP af-
ter two weeks for a blood pressure check……… 
Postnatal care is very rare, I should think, one in the 
last two years where they’ve come to have their blood 
pressure monitor and still on pills. (Participant 2—
General Practitioner)
Discussion
This is the first study to explore in- depth the views and 
experiences of a group of UK clinicians’ on postnatal 
management of women who had HDP, their awareness 
of relevant NICE guidance and barriers and facilitators to 
implementation of NICE recommendations.
Several important barriers to implementation of NICE 
guidance were highlighted including lack of postnatal 
care plans and pathways, lack of continuity, poor compli-
ance with antihypertensive medication management, 
uncertainty around responsibility for postnatal care and 
in some cases, women’s lack of awareness of the impor-
tance of postnatal monitoring and follow- up. Views of 
current routine postnatal provision led some clinicians 
based in secondary care to consider that women in some 
circumstances should remain under their care for longer, 
rather than be discharged to non- specialist ‘routine’ 
primary care services. Clinicians acknowledged the need 
for better planning, increased awareness of NICE guid-
ance, better coordination of care across health settings, 
better and timely information for women and a greater 
role for MDT planning.
More clinicians will be required to plan and imple-
ment guidance to support the management of increasing 
numbers of women likely to experience HDP.3 4 For all 
clinicians, awareness that HDP can persist beyond the 
birth, knowledge of signs and symptoms of de novo onset, 
and the sharing of relevant information with women and 
their families14 24 could make a significant difference to 
outcome.
Findings indicate that the postnatal period remains a 
neglected aspect of a woman’s maternity care, despite 
increasing evidence of widespread and chronic physical 
and psychological maternal morbidity.25 Women in the 
UK are still more likely to die following birth than during 
pregnancy26; however, maternal deaths as a result of 
HDP declined considerably between 2009 and 2011 (11 
women died, 0.42 per 100 000 maternities, 95% CI 0.21 
to 0.76) and 2012 and 2014 (three women died, 0.11 per 
100 000 maternities, 95% CI 0.02 to 0.34)27; this reduc-
tion attributed to implementation of research, audit and 
evidence- based guidance.
While the Mothers and Babies: Reducing Risk through 
Audits and Confidential Enquiries (MBRRACE) (UK) 
findings are very reassuring, none of the opportunities 
highlighted to further improve care referred to the post-
natal period and beyond, despite 11 of the 14 maternal 
deaths between 2009 and 2014 occurring between 1 and 
42 days of giving birth.27 With evidence of risks of HDP on 
a woman’s future cardiovascular health,4 risk of reoccur-
rence of HDPs in a future pregnancy,11 and evidence that 
around a third of eclampsia cases and more than half of 
strokes associated with severe pre- eclampsia occur postna-
tally,6 28 postnatal care cannot be ignored.
The variation in content of care and lack of aware-
ness of antihypertensive medication as recommended by 
NICE3 13 found in the current study supports a small online 
survey of UK clinicians of antihypertensive adjustment 
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postnatally, which aimed to explore prescribing clinicians’ 
approaches to down titration of antihypertensive medica-
tion following birth.2 Of the 101/390 (26%) secondary 
and primary care clinicians approached who completed 
the survey, labetalol was the the most common antihy-
pertensive drug prescribed. Most clinicians reported 
adhering to national guidelines when reducing but not 
increasing women’s medication, with wide variation in 
practice.
The same research team subsequently published results 
of a feasibility trial of women’s self- management of BP.29 
Ninety- one (49%) of 186 women approached from 5 NHS 
units who had gestational hypertension or pre- eclampsia 
which required postnatal antihypertensive management 
were recruited and randomised to self- management 
(n=45) or usual care (n=46). The self- management 
intervention, which commenced following inpatient 
discharge, comprised daily home BP monitoring and 
automated medication reduction via telemonitoring. 
Feasibility outcomes included recruitment, retention and 
compliance with follow- up; 90% of women completed 
follow- up. Intervention women had lower BP, with the 
largest difference at 6 weeks postnatally. Diastolic BP was 
significantly lower in the intervention group to 6 months 
postnatally. Study limitations included that women were 
mostly white and from middle- class backgrounds; never-
theless, a larger randomised controlled trial with BP as 
the primary outcome is an important next step.29
Robust evidence to support postnatal antihyperten-
sive management is needed. This includes studies which 
directly compare outcomes of different hypertensive 
drugs and BP thresholds for medication adjustment,29 
and studies which address why there are disparities in 
outcomes among women of different ethnic groups, 
such as the recent finding that women of black ethnicity 
with chronic hypertension had a significantly greater 
risk of adverse perinatal outcomes compared with white 
women.30
What is clear based on our findings is that greater 
awareness of, and compliance with, NICE guidance3 13 14 
could enhance some postnatal outcomes. These include 
developing postnatal care plans and pathways during 
pregnancy13 to inform appropriate timing of transfer 
from secondary to primary care services and the clini-
cians who should be involved. Greater involvement of 
the MDT could be of benefit, with consideration of a 
postnatal MDT consultation to assess women’s health 
needs going forward, and the development of a care plan 
which could be shared with the woman’s GP.25 Continuity 
of midwifery care could be supported postnatally for as 
long as the woman and midwife felt was necessary, with 
a coordinating clinician identified (eg, the midwife or 
GP) to sign- post women for additional medical support 
as and when required. Information on breast feeding 
when taking antihypertensive drugs should be offered 
to all women,3 13 preferably when medication is first 
prescribed, to enable women to make informed decisions 
about infant feeding. Our findings clearly highlight that 
all clinicians should familiarise themselves with current 
guidance on recommended antihypertensive medica-
tion for women who are or are not breast feeding, even 
if not the prescribing clinician, to ensure they can advise 
women appropriately.3 13
Some clinicians in our study were advising women 
on approaches to self- manage their health to reduce 
future risk of the consequences of HDP on their health, 
including lifestyle advice. Of concern is that a lack of an 
appropriate care pathway postnatally could delay treat-
ment, including preconception care planning, to poten-
tially benefit outcomes of subsequent pregnancies. NICE 
recommends weight management support and other life-
style behaviours are discussed with women, with advice 
reflecting women’s individual circumstances, and reiter-
ated as needed at each primary care consultation.3 13 14 
Women at risk of future CVD based on their pregnancy 
history will potentially require more frequent screening 
beyond the postnatal period, although robust evidence is 
needed of the benefit of this.10 What NICE guidance does 
not currently specifically support is flexibility with respect 
to the duration of postnatal care an individual woman 
may require. Current guidance3 13 14 ‘assumes’ that all 
women are ‘recovered’ from their pregnancy and birth 
within the 6–8 weeks postnatal period, when this may not 
be the case. We do not yet have evidence of what model 
of postnatal care would be of most benefit for women 
who have medically complex pregnancies, an area which 
needs urgent attention.25
As a qualitative study, generalisability may be limited. 
The study was undertaken in London and it is likely that 
clinicians’ experiences will differ in terms of the popu-
lation of women they are likely to care for, the environ-
ment of care and range of specialist maternity services 
they can access. However, there were several strengths. 
We interviewed a wide range of secondary and primary 
care- based NHS clinicians based in inner city and urban 
areas, providing care to women and families from a 
wide range of ethnicities, sociodemographic and socio-
economic backgrounds. Some clinicians were linked 
to tertiary NHS maternity units which care for women 
with the most serious medical complications and as 
such were more likely to be ‘experts’ in HDP manage-
ment and to have greater insight into some of the issues 
raised.
Conclusion
Evidence of longer term maternal health consequences 
following HDP is accumulating. Clinicians should ensure 
that relevant NICE guidance is implemented, that they 
are familiar with guidance and that women are involved 
in decisions about ongoing care and why this is important. 
The continued low priority accorded to postnatal care 
means that missed opportunities to improve outcomes 
for women, their infants and families will continue.
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